Broad definition of digital health weakens sector

Digital health is having a moment as a healthcare subsector, reaping in billions in funding over the last several years, but its broad definition is bringing some confusion to its cause, according to a CNBC report.

The lack of a clear definition was especially apparent during the J.P. Morgan Healthcare conference in San Francisco, where digital health was “so overused and over-hyped, it’s no longer clear what it means,” CNBC reported. And digital health providers vary widely in what they offer, in terms of solutions and quality.

From clinical solutions to wellness apps and tools, digital health is being broadly defined as the intersection of health and technology. That big definition lumps in too many products, and doctors may need a more finely curated list of available solutions to recommend to patients.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.